Lumibird SA

Paris Stock Exchange LBIRD.PA

Lumibird SA Price to Sales Ratio (P/S) on February 05, 2025: 0.76

Lumibird SA Price to Sales Ratio (P/S) is 0.76 on February 05, 2025, a -37.89% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Lumibird SA 52-week high Price to Sales Ratio (P/S) is 1.59 on March 06, 2024, which is 108.03% above the current Price to Sales Ratio (P/S).
Lumibird SA 52-week low Price to Sales Ratio (P/S) is 0.71 on October 21, 2024, which is -7.00% below the current Price to Sales Ratio (P/S).
Lumibird SA average Price to Sales Ratio (P/S) for the last 52 weeks is 1.12.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Paris Stock Exchange: LBIRD.PA

Lumibird SA

CEO	Dr. Marc Le Flohic
IPO Date	April 12, 2000
Location	France
Headquarters	2 rue Paul Sabatier
Employees	1,053
Sector	Technology
Industries 3D Printing Biotechnology Defense & Military Drones Eyewear Hardware & Electronics Medical Instruments Robotics

Description

Lumibird SA designs, manufactures, and sells various lasers for the scientific, industrial, and medical applications worldwide. It operates in two divisions, Photonics and Medical. The Photonics division offers solid-state lasers, high power laser diodes, fiber lasers, fiber amplifiers and components, photonics solutions for time-of-flight lidar and range-finding, and doppler lidar systems for wind measurement. Its products are used in various applications, such as industrial and scientific, defense and space, and lidar sensors. The Medical division provides medical and ophthalmological solutions from diagnosis to laser treatment. The company was founded in 1970 and is headquartered in Lannion, France.

Key trends

Past 5 years